Peptide handling
Thymosin Alpha-1 reconstitution calculator
Reconstitution calculator for Thymosin Alpha-1, prefilled for its 5 and 10 mg vials. Get the concentration, the dose volume and the U-100 syringe reading.
Start from a compound
Fills the vial size and a starting water volume. Only compounds with a citable range fill a dose.
The second is the question asked once the syringe is already filled, or when checking a vial someone else reconstituted.
1 mg = 1,000 mcg. Published figures are usually micrograms; vial labels are milligrams.
- Draw to
- 48 unitson a U-100 syringe
- Dose
- 1200 mcg
- Dose volume
- 0.48 mL
- Concentration
- 2.5 mg/mL
- Per unit
- 25 mcg
- Doses per vial
- 4whole doses; a partial one is not counted
Shown on a 50-unit (0.5 mL) U-100 syringe, the smallest that holds this draw.
Thymosin Alpha-1 — Limited human data
From human studies that are small, early-phase, or for a different indication than the one this range is usually cited for. The prefilled dose is the low end of that range, twice weekly.
Vial size and water volume are a starting point for the arithmetic, not a recommendation.
Adding more water makes the same dose a larger, easier-to-read mark on the syringe. It does not change how many doses the vial holds.
Vial sizes and starting volume
Thymosin Alpha-1 is commonly supplied in 5 mg and 10 mg vials. The calculator opens on a 5 mg vial with 2 mL of bacteriostatic water — a starting point for the arithmetic, not a recommendation. Change either and everything recalculates.
That combination gives 2.5 mg/mL, so one insulin unit holds 25 mcg and a 1200 mcg dose is 48 units.
What dose to enter
A range of 1200–1600 mcg per dose can be cited for Thymosin Alpha-1, twice weekly. The dose field opens at the low end of it.
Limited human data
From human studies that are small, early-phase, or for a different indication than the one this range is usually cited for.
- Thymosin alpha 1: A comprehensive review of the literature. — Review. Comprehensive literature review covering the compound's approved-outside-the-US status and general dosing use.
- Thymosin α1 and Its Role in Viral Infectious Diseases: The Mechanism and Clinical Application. — Review. Reviews mechanism and clinical application in viral disease; supporting context, not a specific dose.
- Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 in Human Clinical Trials. — Human clinical trial review. Review of human clinical trial safety and efficacy data underlying this compound's tier.
- Pharmacokinetics of thymosin alpha 1 after subcutaneous injection of three different formulations in healthy volunteers. — Human pharmacokinetic study. Human pharmacokinetic study of subcutaneous dosing in healthy volunteers.
- Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review. — Human clinical systematic review. Systematic review of human patient data in a different indication (pancreatitis), supporting the human-limited tier rather than the twice-weekly schedule specifically.
Related
- Thymosin Alpha-1 — the product page, with its current batch.
- Bacteriostatic water — what goes in the vial.
- Peptide reconstitution calculator — the general version, with the blend and half-life calculators alongside it.
- Dosing reference — published schedules, each with the evidence behind it.
For research use only. This tool performs arithmetic on figures you supply — it is not medical guidance and does not recommend a dose for any compound.